Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Effects Of Korea's New Drug-Pricing System Still Murky

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Nearly a year after the South Korean Health Ministry announced new policies aimed at eradicating bribery and promoting more transparent drug pricing, effects of a new drug-pricing system remain unclear, industry watchers say

You may also be interested in...



Pricing And Commercial Strategies For Emerging Markets Need To Be Built Into Drug Development Programs Early - DIA Conference

CHICAGO - Emerging markets represent a plethora of opportunity for multinational pharma companies, but they also represent a confusing mix of pricing and reimbursement policies that change rapidly and are not always clear

Pricing And Commercial Strategies For Emerging Markets Need To Be Built Into Drug Development Programs Early - DIA Conference

CHICAGO - Emerging markets represent a plethora of opportunity for multinational pharma companies, but they also represent a confusing mix of pricing and reimbursement policies that change rapidly and are not always clear

Korea Moves To Cut Drug Prices Of Seven Pharma Companies Over Rebates

SEOUL - In its first action following a warning in 2009 about drug rebates, the Korea Ministry of Health and Welfare is moving to cut market prices for 131 products manufactured by seven local Korean pharma companies by as high as 20%

Related Content

UsernamePublicRestriction

Register

LL025498

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel